STAGE III PROSTATE CANCER
Clinical trials for STAGE III PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to control prostate cancer with fewer side effects
Disease control OngoingThis study looks at a type of radiation therapy called high-dose brachytherapy for men with prostate cancer that hasn't spread. Doctors place tiny radioactive sources directly into the prostate to kill cancer cells. The goal is to control the disease while reducing side effects. …
Matched conditions: STAGE III PROSTATE CANCER
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated May 17, 2026 04:10 UTC
-
New radiation approach aims to zap recurrent prostate cancer with fewer side effects
Disease control OngoingThis early-stage study tests a high-precision radiation technique called stereotactic body radiation therapy (SBRT) in 26 men whose prostate cancer has returned after surgery. The main goal is to find the safest and most effective dose by monitoring side effects. The approach tar…
Matched conditions: STAGE III PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 04:00 UTC
-
Promising combo tackles tough prostate cancer
Disease control OngoingThis study tests a three-part treatment for men with intermediate or high-risk prostate cancer: a drug called enzalutamide, radiation therapy, and hormone therapy. The goal is to see how safe the combination is and how well it controls the cancer. About 25 men will take part, and…
Matched conditions: STAGE III PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
High-Dose radiation zaps prostate tumors with less harm to healthy tissue
Disease control OngoingThis study tests a special type of radiation called stereotactic body radiotherapy (SBRT) for men with high-risk prostate cancer that has not spread. SBRT delivers a very focused, high dose of radiation directly to the tumor, aiming to kill cancer cells while sparing normal tissu…
Matched conditions: STAGE III PROSTATE CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:01 UTC